ReviewInternational journal of hematology2022

FLT3-inhibitor therapy for prevention and treatment of relapse after allogeneic hematopoietic cell transplantation.

Francesca Biavasco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.